Anastrozole 1mg

NOVO-PHARM ARIMIDEX – ANASTROZOLE GENERAL DESCRIPTION

Arimidex is a drug product of the aromatase inhibitor group. The drug is produced as tablets with the active agent Anastrozole. The drug first appeared in pharmacology in 1995. It was originally used in medicine to treat cancerous tumors in mammary glands with a high estrogen receptor concentration.

Arimidex is almost never recommended to tumor patients today, but the drug is widely used in bodybuilding and other sports by athletes. The primary purpose of using Arimidex is to avoid gynecomastia effects, fluid retention and other adverse reactions associated with estrogen that occur during and after the anabolic drug cycle. Anastrozole 1mg

NOVO-PHARM ARIMIDEX – ANASTROZOLE BENEFITS

Arimidex has gaine/d a great deal of popularity among training athletes who use anabolic steroids when strengthening their body. Many synthetic testosterone-base/d drugs cause adverse reactions due to their high aromatization, manifested in the form of gynecomastia, excessive swelling, and accumulation of fluid in muscle tissue. During the cycle itself, Anastrozole prevents these effects. Anastrozole 1mg

 The drug’s action can significantly increase the body’s anabolic hormone production.

Generally speaking, the drug has several positive effects on the body:

• significant suppression of aromatization in the body – by 80% of the initial value;
• pronounced inhibitory effect on the aromatase enzyme;
• blocked estrogens concentration;
• rapid effect of the drug – the highest concentration of the active agent in the body is observed 2 hours after intake, which makes it possible to suppress aromatization as soon as possible.

For athletes, the aromatase blocker often prevents hypertension, as high blood pressure is often observe/d during a strongly aromatizing steroid cycle. During such a cycle, the production of natural testosterone in the body often declines dramatically, causing a decrease in athletes’ sexual desire and sexual function problems. The aromatase blocker restores the body’s normal endogenous male hormone production.

Arimidex is not considered an antiestrogen because it does not restore the body properly. After anabolic androgenic drugs are use/d during PCT.

NOVO-PHARM ARIMIDEX – ANASTROZOLE POSSIBLE SIDE EFFECTS

The athlete’s general condition benefits from a moderate concentration of estrogen in the male body. Estrogen hormones increase androgen receptor susceptibility and the efficacy of steroid cycles, while anabolic and protective effects characterize the hormones themselves.

The use of high doses of aromatase inhibitors could lead to unwanted side effects such as slowe/d down muscle growth, pain in the joints, reduce/d bone strength, reduced libido and a decrease in the general state of the body, depresse/d mood, increase/d cholesterol concentration. Exceeding Arimidex’s period of use can result in pronounce/d hormonal disturbances that have a negative impact on the athlete’s overall health. Novo-pharm Arimidex is much more easily tolerate/d by the body compare/d to antiestrogens without causing severe side effects.

NOVO-PHARM ARIMIDEX – ANASTROZOLE ADMINISTRATION AND DOSAGE

In sports, Novo-pharm Arimidex can be use/d for two purposes, on which the optimal dosage of the drug depends:

• to prevent possible gynecomastia and other aromatization symptoms – 0.5 mg Arimidex every other day. Anastrozole 1mg

The aromatase inhibitor use period should not exceed 2 weeks. This time is necessary for all positive properties to be manifeste/d.

NOVO-PHARM ARIMIDEX – ANASTROZOLE COMBINED CYCLES

Basically, the method of using aromatase inhibitors means that Arimidex is only use/d when gynecomastia symptoms (itching, redness in the nipple area, swelling of mammary glands) are present. This method, however, is not particularly advisable. Arimidex is best use/d in a combine/d cycle, which may look like this:

1. For a cycle of anabolics with a short half-life (Methandrostenolone, testosterone propiontate) – after 10 days of the cycle users should test for estradiol, while adding 0.5 mg of Anastrozole every 2 days. After 10 days of the cycle, the tests are repeate/d and the dosage of Arimidex is adjuste/d accordingly.
2. For a cycle of steroid drugs with long esters (Sustanon, testosterone cypionate or enanthate) – after 3-4 weeks of the cycle users should test for estradiol, while adding 0.5 mg of the aromatase inhibitor every two days. After 10 days, the tests are repeate/d and the dosage is adjuste/d base/d on the results.

Arimidex doses may be adjuste/d base/d on the athlete’s personal state of health.